News for 'Sun Pharmaceutical Industries Ltd'

India withdraws policy to cap nonessential pharma prices

India withdraws policy to cap nonessential pharma prices

Rediff.com23 Sep 2014

Ties between India and the United States have been strained in recent years because of trade policies and patent disputes.

Why Doctors Stopped Being Gods

Why Doctors Stopped Being Gods

Rediff.com15 Sep 2022

I got to know that every referred case for angiography and angioplasty got a kickback of Rs 5,000 and Rs 15,000 respectively. Seeing this trend, doctors started paying referring doctors Rs 1 lakh in advance and adjusting it as and when patients came in. This menace slowly spread its tentacles all over the medical field, including radiological diagnostics and biochemistry laboratories. For every test ordered, 20 per cent of the bill was given back to the referring doctor. This led to doctors recommending unnecessary tests. The pharmaceutical companies also saw burgeoning business. Acclaimed doctors were given televisions sets, refrigerators, air conditioners and cars depending upon the prescriptions. General practitioners would prescribe unnecessary drugs, and were given returns in cash. A fascinating excerpt from Dr Upendra Kaul's When The Heart Speaks.

Imported raw material scarcity hits FMCG firms

Imported raw material scarcity hits FMCG firms

Rediff.com25 Apr 2020

Industry officials say the crunch has not only affected manufacturing of edibles but even of items like nozzle pumps and other goods used in packaging.

FIPB clears 7 pharma FDI proposals, defers 3

FIPB clears 7 pharma FDI proposals, defers 3

Rediff.com5 Jul 2013

The FIPB, headed by Department of Economic Affairs Secretary Arvind Mayaram, discussed 30 foreign direct investment proposals, including 10 from pharma sector.

Mukesh Ambani, Dilip Shanghvi among 11 players to make banking easier!

Mukesh Ambani, Dilip Shanghvi among 11 players to make banking easier!

Rediff.com20 Aug 2015

Payments banks will mainly deal in remittance services and accept deposits of up to Rs 1 lakh.

'Tamil Nadu is one of India's most industrialised states'

'Tamil Nadu is one of India's most industrialised states'

Rediff.com9 Sep 2015

The UK has responded to PM Modi's call to 'Make in India' by launching great collaborations in January 2015.

NPPA slaps Rs 300-crore penalty on Novartis

NPPA slaps Rs 300-crore penalty on Novartis

Rediff.com13 Oct 2014

Drug major Novartis has been slapped with a Rs 300-crore penalty by drug regulator NPPA for overcharging consumers on sale of Voveran, its best-selling painkiller medicine.

Sensex logs gains for 5th day in choppy trade, up 72 points

Sensex logs gains for 5th day in choppy trade, up 72 points

Rediff.com30 May 2016

The broader markets outperformed the benchmark indices- BSE Midcap and Smallcap indices gained 0.4% each

India eyes oil-for-drugs deal with Venezuela to recoup pharma cash

India eyes oil-for-drugs deal with Venezuela to recoup pharma cash

Rediff.com18 May 2016

Like pharmaceutical companies globally - which used to enjoy a preferential exchange rate in Venezuela - Indian producers have been left badly stung by the collapse of the bolivar currency

Sensex ends flat; banks soar, GAIL, RIL slip

Sensex ends flat; banks soar, GAIL, RIL slip

Rediff.com10 Dec 2014

The 30-share Sensex closed up 34 points at 27,831 and the 50-share Nifty ended up 15 points at 8,356.

Rs 1-lakh-cr market-cap club now has 18 firms

Rs 1-lakh-cr market-cap club now has 18 firms

Rediff.com23 Aug 2014

In 2008, the 13 companies on the list accounted for 34 per cent of the overall m-cap.

Bulk drug prices may rise this fiscal

Bulk drug prices may rise this fiscal

Rediff.com15 Apr 2014

The industry feels that prices of active pharmaceutical ingredients (APIs) can go up in the range of 5-15 per cent.

Chanda Kochhar skips ED date; to be summoned again

Chanda Kochhar skips ED date; to be summoned again

Rediff.com10 Jun 2019

The agency is also preparing to analyse the details of assets of the Kochhars and others so that they can be provisionally attached under the Prevention of Money Laundering Act

Govt revises FDI norms to shield firms from takeover

Govt revises FDI norms to shield firms from takeover

Rediff.com18 Apr 2020

The government on Saturday made its prior approval mandatory for foreign investments from countries that share land border with India to curb 'opportunistic takeovers' of domestic firms following the COVID-19 pandemic, a move which will restrict Foreign Direct Investment from China.

Brick-and-mortar billionaires back on Forbes rich list

Brick-and-mortar billionaires back on Forbes rich list

Rediff.com20 Oct 2016

Top 100 billionaires see their wealth rise 10%; top 20 account for half of total wealth of top 100.

Will Sudhir Valia, Suraksha's 'deal maker' manage to bag Jaypee Infra?

Will Sudhir Valia, Suraksha's 'deal maker' manage to bag Jaypee Infra?

Rediff.com7 Jul 2021

With the Jaypee acquisition, the Suraksha group, which made lenders an offer of Rs 7,736 crore, will be able to expand its footprint in north India after making inroads in Mumbai's real estate market over the past year. Sudhir Valia, the promoter, was a co-founder and executive director of India's biggest pharmaceutical firm, Sun Pharmaceuticals, and is a close relative of Dilip Shanghvi.

Stock advice: Readers' queries answered!

Stock advice: Readers' queries answered!

Rediff.com14 Aug 2019

Ajit Mishra, Vice President, Research, Religare Broking, answers readers' stock market queries. Ajit will offer his unbiased views on a weekly basis

Myanmar allows traffic rights to Indian airlines

Myanmar allows traffic rights to Indian airlines

Rediff.com10 Jun 2013

At present, there is no direct air connectivity between India and Myanmar.

Drugmakers draw more FDA scrutiny as US imports rise

Drugmakers draw more FDA scrutiny as US imports rise

Rediff.com13 Sep 2013

And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.

How the private sector has stalled India's reforms

How the private sector has stalled India's reforms

Rediff.com9 Jul 2018

'The failures of private businessmen have set back the process of market-oriented reform, though that is the only way forward,' argues T N Ninan.

Stocks you must buy, hold or exit in the New Year

Stocks you must buy, hold or exit in the New Year

Rediff.com26 Dec 2019

Ajit Mishra, Vice President, Research, Religare Broking, answers readers's queries on stocks they own or want to buy.

In 2013, political parties received Rs 11.14 crore from anonymous donors

In 2013, political parties received Rs 11.14 crore from anonymous donors

Rediff.com25 Jun 2014

As per the law, political parties are to declare a list of their political donors. However, as per the latest report, political parties continue to enjoy donations without providing their names or addresses, reports Vicky Nanjappa

Why 'She' is uncomfortable in Emami's basket of brands

Why 'She' is uncomfortable in Emami's basket of brands

Rediff.com21 Dec 2017

One of the reasons for the failure, say industry experts and financial analysts, is that Emami strayed too far from its core with sanitary napkins.

Why Vietnam Beckons

Why Vietnam Beckons

Rediff.com17 Nov 2015

'The success of the country's economic policies is affirmed by receipt of FDI of $15 billion last year, the highest in the Asia-Pacific after China and India, and well ahead of Indonesia, Australia, Singapore, Malaysia and Thailand,' notes Ambassador Talmiz Ahmad.

Record spike in deaths as India COVID-19 tally tops 4.25 lakh

Record spike in deaths as India COVID-19 tally tops 4.25 lakh

Rediff.com23 Jun 2020

As the death toll in the country from coronavirus jumped by a record 445 to 13,699, the Centre maintained that the number of infections per lakh population was among the lowest in the world. The new cases surged by over 10,000 for the 11th day in a row and rose by 14,821 to take the total to 4,25,282, according to health ministry data.

Indian pharma, Taiwan tech lure smart money as stocks tumble

Indian pharma, Taiwan tech lure smart money as stocks tumble

Rediff.com4 Sep 2015

Asia's falling stocks have triggered an exodus of funds from the region.

Pharma in 2014: Deals worth billions and fines worth millions

Pharma in 2014: Deals worth billions and fines worth millions

Rediff.com26 Dec 2014

In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.

Markets end in green as Fed rate hike fears dim

Markets end in green as Fed rate hike fears dim

Rediff.com18 Aug 2016

Financials were the top gainers lead by private lenders ICICI Bank and HDFC Bank

India, China sign business deals worth $3.4 billion

India, China sign business deals worth $3.4 billion

Rediff.com18 Sep 2014

IndiGo Airlines signs $2.6-billion leasing and financing MoU with Industrial and Commercial Bank of China.

First salary: 'In 1971, I was paid Rs 75 per month'

First salary: 'In 1971, I was paid Rs 75 per month'

Rediff.com17 Jul 2019

Rediff readers tell us what their first salary was and what it meant to them at the time.

India defends right to issue drug 'compulsory licences'

India defends right to issue drug 'compulsory licences'

Rediff.com23 Mar 2016

The USTR has placed India on its "priority watch" list for two years in a row, saying the country's patent laws unfairly favour local drug makers.

Energy, health care sectors gain from Modi's UK visit

Energy, health care sectors gain from Modi's UK visit

Rediff.com15 Nov 2015

Prime Minister Narendra Modi's three-day visit to Britain has seen India and the UK agreeing on Rs 90,000 crore deals.

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Rediff.com6 Dec 2018

Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.

From Rs 20K to Rs 8,000 crore: Emami's amazing success story

From Rs 20K to Rs 8,000 crore: Emami's amazing success story

Rediff.com30 Sep 2014

The Zandu business grew rapidly, and we became debt-free within two years of the deal.

India to buy Iranian oil despite US sanctions: Pradhan

India to buy Iranian oil despite US sanctions: Pradhan

Rediff.com8 Oct 2018

"We will be guided by our national interest," he said.

FDA raises concern over US unit: Wockhardt

FDA raises concern over US unit: Wockhardt

Rediff.com28 May 2014

Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.

India's current account deficit: Solution lies in policy reforms

India's current account deficit: Solution lies in policy reforms

Rediff.com7 Oct 2015

It is domestic policy distortions and inaction to correct them that lie behind the large CADs.

Why is Novartis likely to lose Tiamulin drug licence?

Why is Novartis likely to lose Tiamulin drug licence?

Rediff.com19 Mar 2014

Legal experts and official sources said the alleged submission of fake documents can also lead to criminal charges against Novartis.

Markets extend gains for the fourth straight day

Markets extend gains for the fourth straight day

Rediff.com22 Feb 2016

The S&P BSE Sensex ended 80 points up at 23,789 while the Nifty50 closed at 7,235, up 24 points.

Global FMCG majors bet big on India despite slowdown

Global FMCG majors bet big on India despite slowdown

Rediff.com25 Dec 2013

India was the flavour of the year, at least in the FMCG sector, as multinationals hiked stakes in their subsidiaries lured by long term potential of the country, while homegrown executives made their way to top hierarchy of global firms in 2013.